METHODS OF TREATING CANCERS EXPRESSING PDGFRALPHA

The invention relates to compositions comprising an olaratumab antibody conjugated to a therapeutic radioisotope, for treatment of cancers that express platelet derived growth factor receptor alpha (PDGFR- alpha), and methods of use thereof. L'invention concerne des compositions comprenant un a...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Hauptverfasser:	WHEATCROFT, Michael Paul, IVASHKEVICH, Alesia
Format:	Patent
Sprache:	eng ; fre
Schlagworte:	CHEMISTRY HUMAN NECESSITIES HYGIENE MEDICAL OR VETERINARY SCIENCE METALLURGY ORGANIC CHEMISTRY PEPTIDES PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
Online-Zugang:	Volltext bestellen
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Beschreibung
Zusammenfassung:	The invention relates to compositions comprising an olaratumab antibody conjugated to a therapeutic radioisotope, for treatment of cancers that express platelet derived growth factor receptor alpha (PDGFR- alpha), and methods of use thereof. L'invention concerne des compositions comprenant un anticorps olaratumab conjugué à un radio-isotope thérapeutique, pour le traitement de cancers qui expriment le récepteur alpha du facteur de croissance dérivé des plaquettes (PDGFR-alpha), et leurs méthodes d'utilisation.